Technology News and Research

RSS

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

QPID Inc. launched today, delivering a new health record intelligence platform and web-based applications that enable health care institutions and clinicians to gain better insights from any Electronic Health Record (EHR).

15 Feb 2013

Personalis announces availability of Genome Services for Research

Personalis, Inc. today announced availability of its Genome Services for Research, focusing on accuracy in sequencing, analysis, and interpretation of human genomes. Personalis believes that accuracy is crucial in medicine, both in research and ultimately in clinical use.

14 Feb 2013

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Santarus, Inc. announced today the U.S. commercial launch of UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis.

14 Feb 2013

Amblyopia screening guidelines updated

The American Association for Pediatric Ophthalmology and Strabismus, the professional body for pediatric eye care, has issued revised guidelines for preschool vision screening based on new evidence.

14 Feb 2013

L-COR Biosciences launches C-DiGit Blot Scanner

Today, LI-COR Biosciences continues to demonstrate its position as a leader in laboratory instrument systems as it announces the launch of the C-DiGit Blot Scanner.

14 Feb 2013

Regeneron fourth quarter total revenues increase to $415 million

Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2012 and provided an update on development programs.

14 Feb 2013

Canada-US-Italian research team develops nature-inspired cocaine biosensor

Since the beginning of time, living organisms have developed ingenious mechanisms to monitor their environment. As part of an international study, a team of researchers has adapted some of these natural mechanisms to detect specific molecules such as cocaine more accurately and quickly. Their work may greatly facilitate the rapid screening-less than five minutes-of many drugs, infectious diseases, and cancers.

14 Feb 2013

Fluke Biomedical receives FDA clearance for ESA615 Electrical Safety Analyzer

The United States Food and Drug Administration (FDA) announced today it has granted the new automated, multifunctional ESA615 Electrical Safety Analyzer 510(k) clearance.

14 Feb 2013

FDA grants IDE approval to STS and ACC to study alternative access approaches for TAVR

The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) have received a unique investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to study "alternative access" approaches for transcatheter aortic valve replacement (TAVR) using the STS/ACC TVT Registry.

14 Feb 2013

Medgenics closes public offering of 5,600,000 shares of common stock and warrants

Medgenics, Inc., the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces yesterday's closing of an underwritten public offering of 5,600,000 shares of common stock and Series 2013-A warrants to purchase up to an aggregate of 2,800,000 shares of common stock.

14 Feb 2013

FOXC2 vital to epithelial-mesenchymal transition in breast cancer

Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.

14 Feb 2013

Link between Jagged-1 protein and bone formation

Researchers from the University of Pennsylvania School of Veterinary Medicine have discovered that a protein called Jagged-1 stimulates human stem cells to differentiate into bone-producing cells.

14 Feb 2013

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.

14 Feb 2013

Weight Watchers International fourth quarter revenues increase 1.7% to $407.9 million

Weight Watchers International, Inc. today announced its fiscal 2012 results for the fourth quarter and full year and provided full year fiscal 2013 earnings guidance.

14 Feb 2013

Mindfulness practitioners gain enhanced control over sensory cortical alpha rhythms

Why does training in mindfulness meditation help patients manage chronic pain and depression? In a newly published neurophysiological review, Brown University scientists propose that mindfulness practitioners gain enhanced control over sensory cortical alpha rhythms that help regulate how the brain processes and filters sensations, including pain, and memories such as depressive cognitions.

14 Feb 2013

DBS can lead to long-term improvement in patients with neuropathic pain

For many patients with difficult-to-treat neuropathic pain, deep brain stimulation (DBS) can lead to long-term improvement in pain scores and other outcomes, according to a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

14 Feb 2013

HealthSaaS, iMPak announce white labeling agreement for their Connected Outcomes Platform

iMPak Health, a subsidiary of Meridian Health, today announced a white labeling agreement with HealthSaaS for their Connected Outcomes Platform. This agreement will enhance iMPak's device offerings by bringing patient data into the clinical workflow as an asset while reducing manual data entry and providing actionable information to healthcare providers.

13 Feb 2013

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.

13 Feb 2013

Setting the scene: Economy, sequestration at heart of Obama's address

His State Of The Union comments will likely highlight the different partisan views on how these automatic spending cuts, set to kick in March 1, could be minimized. Republicans continue to press for changes in entitlement programs, such as Medicare.

13 Feb 2013

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, is showcasing at MD&M West (Hall D, Booth# 1751) Dow Corning® QP1 liquid silicone rubber (LSR) grades that give medical device manufacturers and fabricators broader material choices for intricate devices and components.

13 Feb 2013

Technology News and Research

Health care staff can use QPID's intelligence engine to gain better insights from EHRs

Personalis announces availability of Genome Services for Research

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Amblyopia screening guidelines updated

L-COR Biosciences launches C-DiGit Blot Scanner

Regeneron fourth quarter total revenues increase to $415 million

Canada-US-Italian research team develops nature-inspired cocaine biosensor

Fluke Biomedical receives FDA clearance for ESA615 Electrical Safety Analyzer

FDA grants IDE approval to STS and ACC to study alternative access approaches for TAVR

Medgenics closes public offering of 5,600,000 shares of common stock and warrants

FOXC2 vital to epithelial-mesenchymal transition in breast cancer

Link between Jagged-1 protein and bone formation

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Weight Watchers International fourth quarter revenues increase 1.7% to $407.9 million

Mindfulness practitioners gain enhanced control over sensory cortical alpha rhythms

DBS can lead to long-term improvement in patients with neuropathic pain

HealthSaaS, iMPak announce white labeling agreement for their Connected Outcomes Platform

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

Setting the scene: Economy, sequestration at heart of Obama's address

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News